Myc Gene Can Boost Efficiency of Myelin-repairing Cells & Managing the Threat of Covid
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, discusses an article about how increasing the activity of the Myc gene can make myelin-repairing cells more efficient, a finding...
27 Joulu 20218min
CALLIPER Trial for Progressive MS Enrolls First Patient & The Benefits of Sun Exposure
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, discusses how Immunic Therapeutics has enrolled a patient in the Phase 2 clinical trial CALLIPER, testing oral IMU-838 for progr...
24 Joulu 20217min
Potential Relapsing MS Therapy Up for FDA Approval & Trying a New Diet with MS
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, discusses how TG Therapeutics is seeking FDA approval for ublituximab, its anti-CD20 monoclonal antibody infusion therapy for RR...
22 Joulu 20219min
NervGen Brings Advanced Imaging to Upcoming Trials & Socializing with MS
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, discusses an article about how NervGen will use Imeka's biomarker imaging technology to measure changes in brain and spinal cord...
20 Joulu 20218min
Cognitive Rehab Is Effective Therapy for MS Cognitive Issues & Managing an MS Bladder
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, discusses how cognitive rehabilitation is an effective, low-risk and low-cost approach to treating cognitive problems of multipl...
17 Joulu 20216min
First Patient Enters Extension Trial Testing Higher Temelimab Doses & How to Hold Space with MS
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, discusses a news article about how the first patient who completed GeNeuro’s ProTEct-MS Phase 2 trial has entered the study's ex...
15 Joulu 20218min
Mesenchymal Stem Cells Show Promise in Preclinical Studies & When MS Feels Like Groundhog Day
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, discusses how mesenchymal stem cells can improve functional abilities and promote the remyelination in rodent models of MS, acco...
13 Joulu 20218min
Cancer Researchers’ Discovery May Benefit MS Research & Five Years of Lemtrada Treatment
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, discusses how in an unexpected discovery, scientists found that increasing the activity of PDGFRA reduces the production of myel...
10 Joulu 20219min
